At ECR 2021 Philips also announced that its Digital Radiography and Fluoroscopy system (CombiDiagnost R90), a remote controlled fluoroscopy system in combination with high-end digital radiography, has received 510(k) clearance from the U.S. Food and Drug Administration. Designed to improve room utilization in a cost effective manner. The versatile system combines a fully digital workflow, UNIQUE image quality and excellent dose management for a wide range of examinations from pediatric to bariatric imaging.
Philips is showcasing its latest advances in diagnostic X-ray during the virtual ECR 2021. During the congress, Philips will host a symposium with a panel of leading physicians: ‘Smart Workflows: Improving imaging productivity and clinical confidence with AI’.
Ad Statistics
Times Displayed: 36815
Times Visited: 623 Reveal Mobi Pro integrates the Reveal 35C detector with SpectralDR technology into a modern mobile X-ray solution. Mobi Pro allows for simultaneous acquisition of conventional & dual-energy images with a single exposure. Contact us for a demo at no cost.
About Royal Philips
Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being, and enabling better outcomes across the health continuum – from healthy living and prevention, to diagnosis, treatment and home care. Philips leverages advanced technology and deep clinical and consumer insights to deliver integrated solutions. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care. Philips generated 2020 sales of EUR 19.5 billion and employs approximately 82,000 employees with sales and services in more than 100 countries.